Table 3. Plasma acyl ethanolamide correlations to SNAQ Scores in female subjects*.
Appetite | Satiety | Food Taste | Normal Intake | Total SNAQ | |
---|---|---|---|---|---|
P-EA | -0.04 | -0.09 | -0.03 | -0.01 | -0.04 |
S-EA | -0.33 | -0.63** | -0.29 | -0.14 | -0.41 |
O-EA | -0.28 | -0.50* | -0.37 | -0.22 | -0.42 |
L-EA | -0.44 | -0.64** | -0.36 | -0.51* | -0.60** |
aL-EA | -0.22 | -0.46* | -0.29 | -0.47* | -0.43 |
DGLA-EA | -0.1 | 0.01 | -0.39 | -0.18 | -0.15 |
A-EA | -0.05 | -0.02 | 0.01 | -0.2 | -0.07 |
D-EA | -0.36 | -0.37 | -0.24 | -0.46 | -0.43 |
DH-EA | 0.63** | 0.59** | 0.54* | 0.31 | 0.63** |
L-EA:DH-EA | -0.69** | -0.81*** | -0.49* | -0.45 | -0.74*** |
Values are Spearman's correlation ρ values after data transformation to a more normal distribution.
Significance of correlations are indicated at
p<0.001,
p<0.01, and
p<0.05 using a 2-tailed assessment.
P-EA - palmitoyl ethanolamide; S-EA - stearoyl ethanolamide; O-EA, oleoyl ethanolamide; L-EA, linoleoyl ethanolamide; αL-EA, alpha-linolenoyl ethanolamide; DGLA-EA - dihomo-gamma-linolenoyl ethanolamide; A-EA - arachidonoyl ethanolamide; D-EA - docosatetraenoyl ethanolamide; DH-EA - docosahexaenoyl ethanolamide